| Tretinoin | Approved Investigational Nutraceutical | DUOX1 | 53905 |
upregulated | Tretinoin results in increased expression of DUOX1 mRNA | 15q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP1 | 1843 |
upregulated | Tretinoin results in increased expression of DUSP1 mRNA | 5q35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP10 | 11221 |
upregulated | Tretinoin metabolite results in increased expression of DUSP10 mRNA | 1q41 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP10 | 11221 |
upregulated | Tretinoin results in increased expression of DUSP10 mRNA | 1q41 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP11 | 8446 |
downregulated | Tretinoin metabolite results in decreased expression of DUSP11 mRNA | 2p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP16 | 80824 |
upregulated | Tretinoin results in increased expression of DUSP16 mRNA | 12p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP2 | 1844 |
upregulated | Tretinoin results in increased expression of DUSP2 mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP26 | 78986 |
downregulated | Tretinoin results in decreased expression of DUSP26 mRNA | 8p12 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP5 | 1847 |
upregulated | Tretinoin results in increased expression of DUSP5 mRNA | 10q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP5P1 | 574029 |
downregulated | Tretinoin results in decreased expression of DUSP5P1 mRNA | 1q42.13 | |
| Tretinoin | Approved Investigational Nutraceutical | DUSP6 | 1848 |
upregulated | Tretinoin results in increased expression of DUSP6 mRNA | 12q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DVL1 | 1855 |
downregulated | Tretinoin results in decreased expression of DVL1 mRNA | 1p36.33 | |
| Tretinoin | Approved Investigational Nutraceutical | DYDC2 | 84332 |
downregulated | Tretinoin results in decreased expression of DYDC2 mRNA | 10q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DYNLL1 | 8655 |
upregulated | Tretinoin results in increased expression of DYNLL1 mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | DYRK2 | 8445 |
upregulated | Tretinoin results in increased expression of DYRK2 mRNA | 12q15 | |
| Tretinoin | Approved Investigational Nutraceutical | DYSF | 8291 |
upregulated | Tretinoin results in increased expression of DYSF mRNA | 2p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DZIP3 | 9666 |
upregulated | Tretinoin results in increased expression of DZIP3 mRNA | 3q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F1 | 1869 |
downregulated | Tretinoin metabolite results in decreased expression of E2F1 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F1 | 1869 |
downregulated | Tretinoin results in decreased expression of E2F1 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F1 | 1869 |
upregulated | Tretinoin results in increased expression of E2F1 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F2 | 1870 |
downregulated | Tretinoin results in decreased expression of E2F2 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F4 | 1874 |
upregulated | Tretinoin results in increased expression of E2F4 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F5 | 1875 |
downregulated | Tretinoin results in decreased expression of E2F5 mRNA | 8q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | E2F8 | 79733 |
downregulated | Tretinoin results in decreased expression of E2F8 mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | EAF2 | 55840 |
downregulated | Tretinoin results in decreased expression of EAF2 mRNA | 3q13.33 | |